Senyo Health With Substance Use Disorder (SUD) in Primary Care

NAEnrolling by invitationINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

September 22, 2025

Primary Completion Date

July 20, 2027

Study Completion Date

December 31, 2027

Conditions
Substance Use DisordersSubstance Abuse
Interventions
BEHAVIORAL

Waitlist

Subjects will have monthly check-in meetings with the Integrated Behavioral Healthcare manager, complete monthly urine tests for substance use, the Timeline Follow Back (TLFB) to gather substance abuse history, and complete baseline questionnaires.

BEHAVIORAL

Senyo App

Subjects will engage with the Senyo Health platform for 12 weeks to deliver Integrated Behavioral Healthcare (IBH) treatment. The Senyo Health platform consists of asynchronous cognitive behavioral therapy modules and weekly check-ins with the IBH care manager. Subjects will also complete a monthly urine test for substances, the Timeline Follow Back (TLFB) to gather substance abuse history, and complete weekly questionnaires.

BEHAVIORAL

Follow-up

Subjects will have monthly check-in meetings with the Integrated Behavioral Healthcare manager, complete monthly urine tests for substance use, the Timeline Follow Back (TLFB) to gather substance abuse history, and complete monthly questionnaires.

Trial Locations (2)

55905

Mayo Clinic in Rochester, Rochester

85259

Mayo Clinic in Arizona, Scottsdale

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Agency for Healthcare Research and Quality (AHRQ)

FED

lead

Mayo Clinic

OTHER

NCT06743282 - Senyo Health With Substance Use Disorder (SUD) in Primary Care | Biotech Hunter | Biotech Hunter